Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001736730-25-000028
Filing Date
2025-04-30
Accepted
2025-04-30 07:02:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-2025annualmeeting.htm DEFA14A 10451
2 camp4therapeuticscorporati.jpg GRAPHIC 529216
3 camp4therapeuticscorporatia.jpg GRAPHIC 410964
  Complete submission text file 0001736730-25-000028.txt   1305906
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42365 | Film No.: 25890884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)